Redefining biopharma innovation: Sanofi’s S$800m Modulus facility in Singapore

Edb.gov.sg

Last Tuesday at 08:00

Html
Text

#EDBWrapped2024: We’re ending 2024 with a recap of this year’s highlights!

#EDBWrapped2024: EDB wishes all a delightful festive season and a Happy New Year! Here’s a recap of what you enjoyed reading in 2024

Check it out

Flexible, fast, and sustainable: How Sanofi is producing the next generation of vaccines and biopharma medicines

Get insights

Adding value and ‘not just costs’: Edwards LifeSciences’ Eric Monzon on Singapore’s MedTech ecosystem

Get insights

Febreze and Gorilla® Glass – Meet the MNCs making products for the world from Singapore

Learn more

Brought to you by

Singapore Economic Development Board 250 North Bridge Road #28-00 Raffles City Tower Singapore 179101

Connect with EDB :

Scan QR code to connect on WeChat

You received this email because you signed up for regular updates on Asian business insights and news.
To contact us or unsubscribe, please use the links below.

Update preferences

Unsubscribe

Share on

Other newsletters from Edb.gov.sg

Redefining biopharma innovation: Sanofi’s S$800m Modulus facility in Singapore Edb.gov.sg
Last Tuesday at 08:00
MedTech’s Top 30 firms say why they’re manufacturing in Singapore Edb.gov.sg
26 days ago
EDB’s S$32m plan to drive corporate venturing Edb.gov.sg
2 months ago

More newsletters from Edb.gov.sg

Redefining biopharma innovation: Sanofi’s S$800m Modulus facility in Singapore

Share on

Other newsletters from Edb.gov.sg

Related newsletters